These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22364389)

  • 1. Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.
    Gentry MS; Romá-Mateo C; Sanz P
    FEBS J; 2013 Jan; 280(2):525-37. PubMed ID: 22364389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
    Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
    FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.
    Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS
    PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.
    Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y
    Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
    Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
    Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P
    PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioassay for Lafora disease and laforin glucan phosphatase activity.
    Sherwood AR; Johnson MB; Delgado-Escueta AV; Gentry MS
    Clin Biochem; 2013 Dec; 46(18):1869-76. PubMed ID: 24012855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex.
    Rubio-Villena C; Garcia-Gimeno MA; Sanz P
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
    Mittal S; Dubey D; Yamakawa K; Ganesh S
    Hum Mol Genet; 2007 Apr; 16(7):753-62. PubMed ID: 17337485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.
    Gayarre J; Duran-Trío L; Criado Garcia O; Aguado C; Juana-López L; Crespo I; Knecht E; Bovolenta P; Rodríguez de Córdoba S
    Brain; 2014 Mar; 137(Pt 3):806-18. PubMed ID: 24430976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.
    Singh PK; Singh S; Ganesh S
    Mol Cell Biol; 2012 Feb; 32(3):652-63. PubMed ID: 22124153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
    Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329.
    Sánchez-Martín P; Raththagala M; Bridges TM; Husodo S; Gentry MS; Sanz P; Romá-Mateo C
    PLoS One; 2013; 8(7):e69523. PubMed ID: 23922729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.